News
Anne Wojcicki lands 23andMe again. What $305 million deal means for company, customers, shareholders
Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki's ...
A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe's co-founder ...
A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne ...
Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to buy 23andMe — the genetic testing company she cofounded.
8d
Stocktwits on MSN23andMe’s $305M Sale To Co-Founder Wojcicki Approved: California Loses Legal Battle Over DNA PrivacyA U.S. bankruptcy judge has cleared 23andMe’s $305 million sale to TTAM Research, a nonprofit led by co-founder Anne Wojcicki ...
By Dietrich Knauth (Reuters) -Genetic testing company 23andMe can proceed with a $305 million sale to the company’s ...
14d
Stocktwits on MSN23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s BidMe Holding said Tuesday that a U.S. bankruptcy court has approved the sale of “substantially all” its assets to TTAM Research Institute, a California-based nonprofit led by company co-founder and ...
A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...
A U.S. district judge put on hold the bankruptcy sale of genetic testing company 23andMe late on Monday, giving California ...
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results